iTTCA-MFF: identifying tumor T cell antigens based on multiple feature fusion
Hongliang Zou1, Fan Yang2, Zhijian Yin2
1School of Communications and Electronics, Jiangxi Science and Technology Normal University, Nanchang, 330003, China. hongliangzou@126.com.
Immunogenetics
|March 5, 2022
Summary
A new computational model, iTTCA-MFF, effectively identifies tumor T cell antigens (TTCAs) using physicochemical properties and machine learning. This method offers a faster, automated approach for cancer research, complementing existing experimental techniques.
Area of Science:
- Computational Biology
- Immunology
- Bioinformatics
Background:
- Tumor T cell antigens (TTCAs) show promise in cancer treatment.
- Experimental identification of TTCAs is costly and time-consuming.
- Automated computational methods are needed to identify TTCAs from peptide sequences.
Purpose of the Study:
- To propose a novel computational model, iTTCA-MFF, for identifying tumor T cell antigens.
- To develop an efficient and accurate method for predicting TTCAs.
Main Methods:
- Encoding peptide sequences using physicochemical (PC) properties and residue pairwise energy content matrix (RECM).
- Utilizing covariance and Pearson's correlation coefficient (PCC) for feature extraction.
- Applying least absolute shrinkage and selection operator (LAASO) for optimal feature selection.
- Employing support vector machine (SVM) for TTCAs identification.
Main Results:
- The iTTCA-MFF model demonstrated promising performance in identifying TTCAs on two independent datasets.
- The combination of PC properties, RECM, and advanced feature selection/classification techniques proved effective.
- Experimental results suggest the model's utility in cancer research.
Conclusions:
- The proposed iTTCA-MFF model provides an effective computational approach for TTCAs identification.
- This method can serve as a valuable complement to traditional experimental techniques.
- The developed model contributes to advancing automated peptide analysis in cancer immunology.
Keywords:
LASSOPhysicochemical propertiesResidue pairwise energy content matrixSupport vector machineTumor T cell antigensMore Related Videos
Related Concept Videos
Tumor Immunotherapy
708
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
708
T Cell Activation and Clonal Selection
7.1K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
7.1K


